retatrutide peptide pill form (RETA-40) 107mg Research Retatrutide, an experimental weight-loss drug,

In contrast, Noom states that their dosing starts at 25% or less of the standard 0.25 mg dose and escalates at a personalized rate. While microdosing GLP-1 medications may provide a more personalized experience, there are still questions regarding the safety of this practice as there are currently no published studies on the process, and the microdoses may come from a compounding pharmacy

This is metabolic health

Providers emphasize that microdosing is not a shortcut or a way to avoid lifestyle changes

Scientists have figured out how the new weight-loss drug, Retatrutide, works at a molecular level

Keeping your gut balanced may increase the production of substances like SCFAs that boost GLP-1